LifeMD (LFMD) Director Joan Larovere Receives Award

What Happened

Joan Larovere, a director of LifeMD, was granted 35,000 restricted shares on 2026-08-11. The shares are reported at $0.00 per share (total reported value $0) and are an award/compensation grant rather than an open-market purchase or sale. The grant vests on June 1, 2027 (see footnote).

Key Details

• Transaction date: 2026-08-11; Form 4 filed: 2026-08-18 (7 days after the transaction).
• Transaction type/code: Award/Grant (A).
• Shares granted: 35,000 restricted shares at $0.00 per share (total $0 as reported).
• Vesting: per filing footnote, the restricted shares vest on June 1, 2027.
• Shares owned after transaction: not specified in the provided filing data.
• Timeliness: The Form 4 was filed 7 days after the reported transaction date, which is beyond the typical 2-business-day filing window for Form 4s.

Context

Restricted share grants are commonly used as executive/director compensation and are subject to vesting conditions; they do not represent an immediate cash purchase or sale. A $0 price on the Form 4 typically reflects the nature of the grant rather than a market-traded purchase. This type of award signals compensation alignment with the company but should not be interpreted alone as a buy or sell signal.